Commercial Baby Foods Aimed at Children up to 36 Months: Are They a Matter of Concern?

Mariana Santos1,2, Filipa Matias1, Isabel Loureiro3

  • 1Food and Nutrition Department, National Health Institute Dr Ricardo Jorge, Av. Padre Cruz, 1649-016 Lisbon, Portugal.

Insights

Many commercial baby foods contain added sugars and are ultra-processed, despite "no added sugar" claims. This study highlights the need for better marketing and promotion of healthier, less processed infant foods.

Area of Science:

  • Nutrition Science
  • Public Health
  • Food Science

Background:

  • Optimal infant and early childhood nutrition is vital for development and long-term health.
  • Commercial baby foods play a significant role in infant diets.
  • Concerns exist regarding the nutritional quality and marketing of these products.

Purpose of the Study:

  • To assess the nutritional quality and marketing of commercial baby foods using the WHO/Europe nutrient profile model.
  • To evaluate the degree of processing in baby foods using the NOVA classification system.
  • To identify non-compliance with nutritional standards and identify ultra-processed products.

Main Methods:

  • Analysis of 191 commercial baby food products from major supermarkets in the Lisbon Metropolitan area (March-July 2021).
  • Application of the WHO/Europe nutrient profile model for nutritional and marketing assessment.
  • Utilized the NOVA classification system to determine the degree of food processing.

Main Results:

  • 34.0% of products contained sugar-contributing ingredients; 13.9% listed sugars, and 15.0% listed fruit juices/concentrates.
  • Despite 69.6% having a "No added sugar" claim, only 35.1% met all nutritional model requirements.
  • 61.8% of products were classified as ultra-processed, with 57.0% targeted at infants under 12 months.

Conclusions:

  • A significant proportion of commercial baby foods fail to meet nutritional standards and are heavily ultra-processed.
  • Marketing claims like "No added sugar" can be misleading.
  • Regulatory measures are needed to ensure appropriate marketing and promote healthier, less processed infant foods.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
466
Piaget's Stage 1 of Cognitive Development01:14

Piaget's Stage 1 of Cognitive Development

The sensorimotor stage, the initial phase of Jean Piaget's theory of cognitive development, spans the first two years of a child's life. During this period, infants actively engage with their surroundings, building cognitive awareness through direct interaction with the world. This interaction is primarily based on sensory perception and motor actions, allowing infants to gradually understand basic physical properties and predict how objects interact within their environment.
Exploration...
863